EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized Care

Zoltán Papp iD, Stephan von Haehling iD, Jan Biegus iD, Beáta Bódi, Rebeka Rita Vágó, Zsófia Pólik, Attila Borbély

ESC Heart Failure · 30.10.2026

DOI: 10.1093/eschf/xvag274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 30.10.2026. Verfasst von Zoltán Papp und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sex is one of the most consistent, yet clinically underexploited, determinants of heart failure phenotype, mechanism and outcome. Building on landmark reviews and the 2024 scientific statement of the Heart Failure Association, which documented well-recognized phenotypic differences but noted that their mechanisms remain only partially defined, this review examines how sex differences in heart failure arise and how firmly they should guide practice. Epidemiologically, female predominance in heart failure with preserved ejection fraction is age- and menopause-dependent rather than lifelong. Mechanistically, sex-divergent hormonal signalling, autonomic tone, coronary microvascular dysfunction and myocardial fibrosis often produce similar phenotypes through different mechanisms: microvascular dysfunction is similarly prevalent in both sexes but linked to fibrosis in women and to atherosclerotic risk factors in men, and oestradiol regulates collagen synthesis in opposite directions in female and male cardiac fibroblasts. Clinically, comorbidities carry divergent prognostic weight by sex. Graded against the strength of evidence, sodium-glucose cotransporter 2 inhibitors show established sex-neutral efficacy, whereas the greater benefit of angiotensin receptor-neprilysin inhibition and mineralocorticoid receptor antagonism in women rests on subgroup signals that await confirmation. Natriuretic peptide concentrations are substantially sex-dependent, yet diagnostic thresholds remain sex-neutral, although sex-specific calibration is methodologically achievable. Women remain underrepresented in heart failure trials and less often referred to specialized care. Heart failure is therefore best understood as a sex-differentiated syndrome whose frameworks were built largely around male-pattern disease. Sex-calibrated trial enrolment, sex-specific biomarker and ejection fraction thresholds, and stratification by menopausal stage are concrete next steps towards personalized care.

Schlagwörter

Stichwörter der Autor:innen

HFpEFHFrEFbiomarkersheart failurepersonalized medicinesex differences

Autor:innen und Institutionen

  • Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
  • German Centre for Cardiovascular Research (DZHK), partner site Göttingen, Göttingen, Germany.
  • Department of Cardiology, Clinical Department of Intensive Cardiac Care, Wroclaw Medical University, Faculty of Medicine, Institute of Heart Diseases, Wroclaw, Poland.
  • Doctoral School of Medical Sciences, University of Debrecen, Debrecen, Hungary.
  • Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

ORCID-Profile: Zoltán Papp, Stephan von Haehling, Jan Biegus

Zitieren

APA

Papp, Z., von Haehling, S., Biegus, J., Bódi, B., Vágó, R. R., Pólik, Z., & Borbély, A. (2026). Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized Care. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag274

Vancouver

Papp Z, von Haehling S, Biegus J, Bódi B, Vágó RR, Pólik Z, et al. Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized Care. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag274

BibTeX
@article{Papp2026,
  author = {Papp, Zoltán and von Haehling, Stephan and Biegus, Jan and Bódi, Beáta and Vágó, Rebeka Rita and Pólik, Zsófia and Borbély, Attila},
  title = {Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized Care},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag274}
}
Kostenlos starten →